Arkolith/Insider Trading/GANX/Form 4/A

Calabrese Salvatore

CHIEF FINANCIAL OFFICERGain Therapeutics, Inc. (GANX) · full profile →Form 4/A · filed May 23, 2022
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2022Buy(P)3K$2.70$8K3K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001415889-22-005491) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML